Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategies.
Felix HoferNiema KazemAndreas HammerFeras El-HamidLorenz KollerAlexander NiessnerPatrick SulzgruberPublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
De novo AF was independently associated with a poor prognosis with a 67% increased risk of long-term cardiovascular mortality. Intensified anti-thrombotic treatment in this high-risk patient population might be considered.
Keyphrases
- poor prognosis
- atrial fibrillation
- acute myocardial infarction
- long non coding rna
- percutaneous coronary intervention
- heart failure
- case report
- left atrial
- cardiovascular events
- left ventricular
- risk factors
- left atrial appendage
- direct oral anticoagulants
- type diabetes
- coronary artery disease
- acute coronary syndrome
- combination therapy
- replacement therapy